PMS-Mirtazapine may be available in the countries listed below.
Ingredient matches for PMS-Mirtazapine
Mirtazapine is reported as an ingredient of PMS-Mirtazapine in the following countries:
- Canada
International Drug Name Search
PMS-Mirtazapine may be available in the countries listed below.
Mirtazapine is reported as an ingredient of PMS-Mirtazapine in the following countries:
International Drug Name Search
Detrax may be available in the countries listed below.
Levamisole is reported as an ingredient of Detrax in the following countries:
International Drug Name Search
Alpaz may be available in the countries listed below.
Alprazolam is reported as an ingredient of Alpaz in the following countries:
Zopiclone is reported as an ingredient of Alpaz in the following countries:
International Drug Name Search
Aclotin may be available in the countries listed below.
Ticlopidine is reported as an ingredient of Aclotin in the following countries:
Ticlopidine hydrochloride (a derivative of Ticlopidine) is reported as an ingredient of Aclotin in the following countries:
International Drug Name Search
Generic Name: brompheniramine and phenylpropanolamine (brome feh NEER a meen/fen ill proe pa NO la meen)
Brand Names: Altatapp, Dibrom, Dibromm, Dimaphen, Dimetapp, Myphetapp
Brompheniramine is an antihistamine. It works against the naturally occurring chemical histamine in your body. Brompheniramine prevents sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.
Phenylpropanolamine is a decongestant. It constricts (shrinks) blood vessels (veins and arteries). This reduces the blood flow to certain areas and allows nasal passages to open up.
Brompheniramine and phenylpropanolamine is used to treat nasal congestion and sinusitis (inflammation of the sinuses) associated with allergies, hay fever, and the common cold.
Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.
Brompheniramine and phenylpropanolamine may also be used for purposes other than those listed in this medication guide.
Phenylpropanolamine, an ingredient in this product, has been associated with an increased risk of hemorrhagic stroke (bleeding into the brain or into tissue surrounding the brain) in women. Men may also be at risk. Although the risk of hemorrhagic stroke is low, the U.S. Food and Drug Administration (FDA) recommends that consumers not use any products that contain phenylpropanolamine.
Do not take more of this medication than is recommended. If your symptoms do not improve, or if they worsen, talk to your doctor.
Do not take brompheniramine and phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.
Before taking this medication, tell your doctor if you have
diabetes,
glaucoma,
any type of heart disease or high blood pressure,
thyroid disease,
emphysema or chronic bronchitis, or
difficulty urinating or an enlarged prostate.
You may not be able to take brompheniramine and phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.
Take brompheniramine and phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.
If you cannot swallow the tablets or capsules, look for a liquid form of the medication.
To ensure that you get a correct dose, measure the liquid form of brompheniramine and phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.
Do not take brompheniramine and phenylpropanolamine for longer than 7 days in a row. If your symptoms do not improve, if they get worse, or if you have a fever, talk to your doctor.
Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.
Symptoms of a brompheniramine and phenylpropanolamine overdose include a dry mouth, large pupils, flushing, nausea, and vomiting.
Brompheniramine and phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine and phenylpropanolamine is taken with any of these medications.
Other, less serious side effects may be more likely to occur. Continue to take brompheniramine and phenylpropanolamine and talk to your doctor or try another similar medication if you experience
dryness of the eyes, nose, and mouth;
drowsiness or dizziness;
blurred vision;
difficulty urinating; or
excitation in children.
Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.
Do not take brompheniramine and phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.
Do not take other over-the-counter cough, cold, allergy, diet, or sleep aids while taking brompheniramine and phenylpropanolamine without first talking to your doctor or pharmacist. Other medications may also contain brompheniramine, phenylpropanolamine, or other similar drugs. You may accidentally take too much of these medicines.
Brompheniramine and phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if brompheniramine and phenylpropanolamine is taken with any of these medications.
Drugs other than those listed here may also interact with brompheniramine and phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.
Many formulations of brompheniramine and phenylpropanolamine are available both over-the-counter and with a prescription. Ask your pharmacist any questions you have about this medication, especially if it is new to you.
In some countries, this medicine may only be approved for veterinary use.
Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Reconcile in the following countries:
International Drug Name Search
Gefart may be available in the countries listed below.
Gefarnate is reported as an ingredient of Gefart in the following countries:
International Drug Name Search
Treating heartburn or irritation of the esophagus caused by gastroesophageal reflux disease (GERD). It may also be used for short-term treatment of ulcers of the stomach or small intestine. It may also be used with certain antibiotics to treat ulcers of the small intestines and to help prevent them from coming back. It may also be used to treat conditions that cause your body to make too much stomach acid (eg, Zollinger-Ellison syndrome). It may also be used for other conditions as determined by your doctor.
Omeprazole Suspension is a proton pump inhibitor (PPI). It works by decreasing the amount of acid produced in the stomach.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Omeprazole Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Omeprazole Suspension. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Omeprazole Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Omeprazole Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Omeprazole Suspension.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Diarrhea; gas; headache; nausea; stomach pain; vomiting.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bone pain; chest pain; dark urine; fast, slow, or irregular heartbeat; fever, chills, or sore throat; red, swollen, blistered, or peeling skin; severe diarrhea; severe stomach pain or cramps; swelling of the hands, ankles, or feet; unusual bruising or bleeding; unusual tiredness; vision changes; yellowing of the eyes or skin.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Omeprazole side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; confusion; fast heartbeat; flushing; increased sweating; severe headache, drowsiness, or nausea; vomiting.
Store Omeprazole Suspension at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Omeprazole Suspension out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Omeprazole Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Nims may be available in the countries listed below.
Nimesulide is reported as an ingredient of Nims in the following countries:
International Drug Name Search